Related Experiment Videos
Nonsurgical myocardial revascularization: initial experience with percutaneous transluminal coronary angioplasty
Insights
Percutaneous transluminal coronary angioplasty (PTCA) effectively dilates narrowed coronary arteries, improving blood flow and relieving angina. This nonoperative procedure showed significant symptom improvement and enhanced myocardial performance in patients with severe coronary artery disease.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Coronary artery atheromata cause significant obstruction, leading to myocardial ischemia and angina pectoris.
- Severe proximal coronary artery narrowings pose a substantial clinical challenge requiring effective treatment modalities.
Purpose of the Study:
- To evaluate the efficacy of percutaneous transluminal coronary angioplasty (PTCA) in dilating severe proximal coronary artery narrowings.
- To assess the impact of PTCA on clinical symptoms and myocardial performance in patients with significant coronary artery disease.
Main Methods:
- Performed 16 percutaneous transluminal coronary angioplasty (PTCA) procedures in 15 patients with severe proximal coronary artery narrowings.
- Lesions were located in the left-anterior descending (LAD), right coronary artery (RCA), and circumflex coronary arteries.
- Assessed procedural success, symptom improvement, and myocardial performance using atrial pacing MUGA ventriculography.
Main Results:
- Successful dilatation was achieved in 9 out of 16 procedures (56%).
- Higher success rates were observed for left-anterior descending (LAD) lesions (70%) compared to right coronary artery (RCA) lesions (40%).
- Successful PTCA resulted in significant symptom improvement and abolition of ischemic ventricular response to stress.
Conclusions:
- Percutaneous transluminal coronary angioplasty (PTCA) is a valuable nonoperative method for treating obstructed coronary arteries.
- PTCA effectively improves myocardial blood flow and enhances cardiac function in selected patients.
- The study highlights PTCA's utility in managing severe coronary artery disease and associated angina pectoris.
Abstract:
Coronary artery atheromata obstruct coronary blood flow and produce myocardial ischemia. Percutaneous transluminal coronary angioplasty (PTCA) was performed to dilate narrowed coronary arteries on 16 occasions in 15 patients with severe proximal coronary artery narrowings and significant clinical angina pectoris. The lesions involved the left-anterior descending (LAD) coronary artery in nine patients (10 dilatation procedures), the right coronary artery (RCA) in five, and the circumflex coronary artery in one. Successful dilatation was achieved on nine occasions (56%): in 7 of the 10 LAD lesions (70%), in 2 of the 5 RCA lesions (40%), but not in the patient with circumflex disease. Successful dilatation was accompanied by a significant improvement in symptoms and in myocardial performance, as judged by atrial pacing MUGA (multigated) ventriculography. The ischemic response of the ventricle to stress the significantly reduced or abolished. PTCA is a useful, nonoperative method for dilating obstructed coronary arteries and for improving myocardial blood flow.